Skip to main content
OpenTrials

Clinical trial condition

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Explore clinical trials studying Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) trial results

Completed

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology

NCT03842163

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • The Prince Charles Hospital Chermside, Australia
  • The Alfred Department of Cardiology Melbourne, Australia
  • Medizinische Universität Innsbruck - Universitätsklinik für Innere Medizin III, Kardiologie Innsbruck, Austria
  • Centre Hospitalier Universitaire de Caen Caen, Cedex, France
View all 18 locations
View Trial Details

Related conditions